2023-2029 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Research & Trends Analysis Report
2023-2029 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Research & Trends Analysis Report
Get latest Market Research Reports on Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization). Industry analysis and Market Report on Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is a syndicated market report, published as Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Research Report . It is complete Research Study and Industry Analysis of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Research, the global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Intermediate CDMO segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Pharmaceutical Company has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal and Metrics, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization). Report Highlights:
(1) Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) segment by type and by application and regional segment by type and by application.
(6) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Intermediate CDMO
API CDMO
Formulation CDMO
Protein CDMO
Gene Therapy CDMO
Cell Therapy CDMO
Market segment by application, can be divided into
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
Market segment by players, this report covers
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup
AcuraBio
Moravek
Ascendia Pharmaceuticals
Ardena
CPL
Arranta Bio
UPM Pharmaceuticals
FUJIFILM Diosynth Biotechnologies
Groupe Parima
TBD Pharmatech
Avid Bioservices
Vetter Pharma
NextPharma
Alcami
NerPharMa
Vetio
Societal CDMO
ten23 health
Piramal Pharma Solutions
MedPharm
Lundbeck
AGC Pharma Chemicals
BioVectra
Pfizer CentreOne
Jubilant Biosys
SEIKAGAKU CORPORATION
Mikart
Adare Pharma Solutions
Fermion
Samsung Biologics
Siegfried Holdings
Boehringer Ingelheim
Jubilant Pharmova Limited
Fareva SA
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
1.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast
1.3 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Share in Global Market, 2018-2029
1.4.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size: China VS Global, 2018-2029
1.5 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Dynamics
1.5.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
1.5.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints
1.5.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Trends
1.5.4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Policy
2 Global Competitive Situation by Company
2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Company (2018-2023)
2.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Concentration Ratio
2.4 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Mergers & Acquisitions, Expansion Plans
2.5 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Company (2018-2023)
3.2 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Chain
4.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Upstream Analysis
4.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Midstream Analysis
4.4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Downstream Analysis
5 Sights by Type
5.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Classification
5.1.1 Intermediate CDMO
5.1.2 API CDMO
5.1.3 Formulation CDMO
5.1.4 Protein CDMO
5.1.5 Gene Therapy CDMO
5.1.6 Cell Therapy CDMO
5.2 By Type, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, 2018-2029
6 Sights by Application
6.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Segment by Application
6.1.1 Pharmaceutical Company
6.1.2 Biotechnology Company
6.1.3 Generic Company
6.1.4 Others
6.2 By Application, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
7.3 North America
7.3.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share
7.4 Europe
7.4.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share
7.6 South America
7.6.1 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.3.2 By Company, U.S. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.4.2 By Company, Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.5.2 By Company, China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.5.3 By Type, China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.6.2 By Company, Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.7.2 By Company, South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.9.2 By Company, India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.9.3 By Type, India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Lonza
9.1.1 Lonza Company Information, Head Office, Market Area and Industry Position
9.1.2 Lonza Company Profile and Main Business
9.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.1.4 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.1.5 Lonza Recent Developments
9.2 Catalent
9.2.1 Catalent Company Information, Head Office, Market Area and Industry Position
9.2.2 Catalent Company Profile and Main Business
9.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.2.4 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.2.5 Catalent Recent Developments
9.3 Patheon (Thermo Fisher Scientific)
9.3.1 Patheon (Thermo Fisher Scientific) Company Information, Head Office, Market Area and Industry Position
9.3.2 Patheon (Thermo Fisher Scientific) Company Profile and Main Business
9.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.3.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.3.5 Patheon (Thermo Fisher Scientific) Recent Developments
9.4 Aenova
9.4.1 Aenova Company Information, Head Office, Market Area and Industry Position
9.4.2 Aenova Company Profile and Main Business
9.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.4.4 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.4.5 Aenova Recent Developments
9.5 Siegfried
9.5.1 Siegfried Company Information, Head Office, Market Area and Industry Position
9.5.2 Siegfried Company Profile and Main Business
9.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.5.4 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.5.5 Siegfried Recent Developments
9.6 Recipharm
9.6.1 Recipharm Company Information, Head Office, Market Area and Industry Position
9.6.2 Recipharm Company Profile and Main Business
9.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.6.4 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.6.5 Recipharm Recent Developments
9.7 Strides Shasun
9.7.1 Strides Shasun Company Information, Head Office, Market Area and Industry Position
9.7.2 Strides Shasun Company Profile and Main Business
9.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.7.4 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.7.5 Strides Shasun Recent Developments
9.8 Piramal
9.8.1 Piramal Company Information, Head Office, Market Area and Industry Position
9.8.2 Piramal Company Profile and Main Business
9.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.8.4 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.8.5 Piramal Recent Developments
9.9 Metrics
9.9.1 Metrics Company Information, Head Office, Market Area and Industry Position
9.9.2 Metrics Company Profile and Main Business
9.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.9.4 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.9.5 Metrics Recent Developments
9.10 AMRI
9.10.1 AMRI Company Information, Head Office, Market Area and Industry Position
9.10.2 AMRI Company Profile and Main Business
9.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.10.4 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.10.5 AMRI Recent Developments
9.11 Famar
9.11.1 Famar Company Information, Head Office, Market Area and Industry Position
9.11.2 Famar Company Profile and Main Business
9.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.11.4 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.11.5 Famar Recent Developments
9.12 WuXi AppTech
9.12.1 WuXi AppTech Company Information, Head Office, Market Area and Industry Position
9.12.2 WuXi AppTech Company Profile and Main Business
9.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.12.4 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.12.5 WuXi AppTech Recent Developments
9.13 Asymchem
9.13.1 Asymchem Company Information, Head Office, Market Area and Industry Position
9.13.2 Asymchem Company Profile and Main Business
9.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.13.4 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.13.5 Asymchem Recent Developments
9.14 Porton
9.14.1 Porton Company Information, Head Office, Market Area and Industry Position
9.14.2 Porton Company Profile and Main Business
9.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.14.4 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.14.5 Porton Recent Developments
9.15 Amatsigroup
9.15.1 Amatsigroup Company Information, Head Office, Market Area and Industry Position
9.15.2 Amatsigroup Company Profile and Main Business
9.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.15.4 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.15.5 Amatsigroup Recent Developments
9.16 AcuraBio
9.16.1 AcuraBio Company Information, Head Office, Market Area and Industry Position
9.16.2 AcuraBio Company Profile and Main Business
9.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.16.4 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.16.5 AcuraBio Recent Developments
9.17 Moravek
9.17.1 Moravek Company Information, Head Office, Market Area and Industry Position
9.17.2 Moravek Company Profile and Main Business
9.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.17.4 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.17.5 Moravek Recent Developments
9.18 Ascendia Pharmaceuticals
9.18.1 Ascendia Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.18.2 Ascendia Pharmaceuticals Company Profile and Main Business
9.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.18.4 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.18.5 Ascendia Pharmaceuticals Recent Developments
9.19 Ardena
9.19.1 Ardena Company Information, Head Office, Market Area and Industry Position
9.19.2 Ardena Company Profile and Main Business
9.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.19.4 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.19.5 Ardena Recent Developments
9.20 CPL
9.20.1 CPL Company Information, Head Office, Market Area and Industry Position
9.20.2 CPL Company Profile and Main Business
9.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.20.4 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.20.5 CPL Recent Developments
9.21 Arranta Bio
9.21.1 Arranta Bio Company Information, Head Office, Market Area and Industry Position
9.21.2 Arranta Bio Company Profile and Main Business
9.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.21.4 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.21.5 Arranta Bio Recent Developments
9.22 UPM Pharmaceuticals
9.22.1 UPM Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.22.2 UPM Pharmaceuticals Company Profile and Main Business
9.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.22.4 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.22.5 UPM Pharmaceuticals Recent Developments
9.23 FUJIFILM Diosynth Biotechnologies
9.23.1 FUJIFILM Diosynth Biotechnologies Company Information, Head Office, Market Area and Industry Position
9.23.2 FUJIFILM Diosynth Biotechnologies Company Profile and Main Business
9.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.23.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.23.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.24 Groupe Parima
9.24.1 Groupe Parima Company Information, Head Office, Market Area and Industry Position
9.24.2 Groupe Parima Company Profile and Main Business
9.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.24.4 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.24.5 Groupe Parima Recent Developments
9.25 TBD Pharmatech
9.25.1 TBD Pharmatech Company Information, Head Office, Market Area and Industry Position
9.25.2 TBD Pharmatech Company Profile and Main Business
9.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.25.4 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.25.5 TBD Pharmatech Recent Developments
9.26 Avid Bioservices
9.26.1 Avid Bioservices Company Information, Head Office, Market Area and Industry Position
9.26.2 Avid Bioservices Company Profile and Main Business
9.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.26.4 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.26.5 Avid Bioservices Recent Developments
9.27 Vetter Pharma
9.27.1 Vetter Pharma Company Information, Head Office, Market Area and Industry Position
9.27.2 Vetter Pharma Company Profile and Main Business
9.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.27.4 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.27.5 Vetter Pharma Recent Developments
9.28 NextPharma
9.28.1 NextPharma Company Information, Head Office, Market Area and Industry Position
9.28.2 NextPharma Company Profile and Main Business
9.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.28.4 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.28.5 NextPharma Recent Developments
9.29 Alcami
9.29.1 Alcami Company Information, Head Office, Market Area and Industry Position
9.29.2 Alcami Company Profile and Main Business
9.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.29.4 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.29.5 Alcami Recent Developments
9.30 NerPharMa
9.30.1 NerPharMa Company Information, Head Office, Market Area and Industry Position
9.30.2 NerPharMa Company Profile and Main Business
9.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Models, Specifications and Application
9.30.4 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Gross Margin, 2018-2023
9.30.5 NerPharMa Recent Developments
9.31 Vetio
9.32 Societal CDMO
9.33 ten23 health
9.34 Piramal Pharma Solutions
9.35 MedPharm
9.36 Lundbeck
9.37 AGC Pharma Chemicals
9.38 BioVectra
9.39 Pfizer CentreOne
9.40 Jubilant Biosys
9.41 SEIKAGAKU CORPORATION
9.42 Mikart
9.43 Adare Pharma Solutions
9.44 Fermion
9.45 Samsung Biologics
9.46 Siegfried Holdings
9.47 Boehringer Ingelheim
9.48 Jubilant Pharmova Limited
9.49 Fareva SA
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Research Methodology:
Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|